Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?

MLA

Al Hariri, Mohammad, et al. “Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?” Journal of Clinical Medicine, vol. 13, no. 2, Jan. 2024, p. 565. EBSCOhost, https://doi.org/10.3390/jcm13020565.

APA

Al Hariri, M., Munder, M., Pfeiffer, N., & Wasielica-Poslednik, J. (2024). Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy? Journal of Clinical Medicine, 13(2), 565. https://doi.org/10.3390/jcm13020565

Chicago

Al Hariri, Mohammad, Markus Munder, Norbert Pfeiffer, and Joanna Wasielica-Poslednik. 2024. “Does Systemic Hematological Therapy Influence the Course of Paraproteinemic Keratopathy?” Journal of Clinical Medicine 13 (2): 565. doi:10.3390/jcm13020565.